# Trade Execution Log

**Model:** Perplexity
**Date:** 2026-02-02

```text

==================================================
üìä ALPACA PRE-FLIGHT STATUS (Perplexity)
==================================================
üí∞ Equity: $1,008.02
üí∏ Buying Power: $716.09

üìÇ Current Positions:
   ‚Ä¢ IBRX: 4 shares @ $6.18 (Current: $6.27)
   ‚Ä¢ NTLA: 3 shares @ $14.24 (Current: $12.95)
   ‚Ä¢ RUN: 12 shares @ $19.50 (Current: $19.00)

üìù Open Orders:
   ‚Ä¢ RUN: STOP SELL 12 shares Stop @ $17.50 (OCO-held)
   ‚Ä¢ NTLA: STOP SELL 3 shares Stop @ $11.85 (new)
   ‚Ä¢ IBRX: STOP SELL 4 shares Stop @ $5.50 (new)
   ‚Ä¢ RUN: LIMIT SELL 12 shares @ $21.90 (new)

==================================================

üìã Parsing Portfolio Recommendation from Clipboard...
--------------------
üìã CLIPBOARD CONTENT:
| ACTION | TICKER | QTY | TYPE  | LIMIT_PRICE | STOP_LOSS | TAKE_PROFIT | REASON                                                                                                                               |
| ------ | ------ | --- | ----- | ----------- | --------- | ----------- | ------------------------------------------------------------------------------------------------------------------------------------ |
| SELL   | NTLA   | 3   | LIMIT | 12.50       | N/A       | N/A         | Analyst downgrades post-FDA lift (JPMorgan $5, Wells Fargo $12). Thesis weakened. Lock entry premium.                                |
| HOLD   | IBRX   | 4   | N/A   | N/A         | 5.50      | N/A         | FDA Type B meeting clear path for BLA resubmission end 2026. QUILT-2.005 85%+ complete. Maintain tight stop below technical support. |
| HOLD   | RUN    | 12  | N/A   | 21.90       | 18.67     | N/A         | VPP partnership catalyst (Jan 28), Q4 earnings Feb 26. Maintain limit sell. Adjust stop if breaks 50SMA.                             |
--------------------

üîé Found 4 trade(s) (Markdown table).

üìâ PROCESSING SELL: NTLA
   üßπ Clearing 1 active order(s) for NTLA before selling.
   ‚úÖ SELL submitted for NTLA

üõ°Ô∏è SYNCING PROTECTION: IBRX (Target Stop: $5.50)
   ‚úÖ Already Protected: Existing stop for IBRX matches $5.50 (new)

üõ°Ô∏è SYNCING PROTECTION: RUN (Target Stop: $18.67)
   üîÑ Updating: Found stop @ $17.50 (held). Replacing with $18.67
   ‚úÖ SUCCESS: Stop-loss update requested for RUN.
```
